ArrowMark Colorado Holdings’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-935,987
| Closed | -$3.47M | – | 340 |
|
|
2018
Q1 | $3.47M | Hold |
935,987
| – | – | 0.03% | 225 |
|
|
2017
Q4 | $2.7M | Hold |
935,987
| – | – | 0.03% | 225 |
|
|
2017
Q3 | $4.2M | Buy |
935,987
+252,368
| +37% | +$1.13M | 0.05% | 209 |
|
|
2017
Q2 | $3.14M | Buy |
+683,619
| New | +$3.14M | 0.04% | 222 |
|
|
2016
Q4 | – | Sell |
-29,194
| Closed | -$236K | – | 480 |
|
|
2016
Q3 | $236K | Hold |
29,194
| – | – | ﹤0.01% | 275 |
|
|
2016
Q2 | $228K | Hold |
29,194
| – | – | ﹤0.01% | 269 |
|
|
2016
Q1 | $225K | Sell |
29,194
-1,650
| -5% | -$12.7K | 0.01% | 254 |
|
|
2015
Q4 | $333K | Hold |
30,844
| – | – | 0.01% | 256 |
|
|
2015
Q3 | $213K | Buy |
30,844
+544
| +2% | +$3.76K | 0.01% | 271 |
|
|
2015
Q2 | $268K | Sell |
30,300
-24,950
| -45% | -$221K | 0.01% | 289 |
|
|
2015
Q1 | $545K | Buy |
+55,250
| New | +$545K | 0.01% | 232 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 316 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 332 |
|
|
2013
Q3 | – | Sell |
-95,891
| Closed | -$784K | – | 278 |
|
|
2013
Q2 | $784K | Buy |
+95,891
| New | +$784K | 0.21% | 64 |
|